Clinical Trial Update: Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated fondaparinux in patients with atrial fibrillation undergoing restoration of normal rhythm. The study completed and results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• ARIXTRA (fondaparinux sodium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Fibrillation, Atrial | Phase 2 | Status: COMPLETED | Results posted: 2012-09-05